Anti-Streptolysin O test
- UID
- MFG/IVD/2023/000113_89e8d53a99969c9ffb913c75f6ee6b05_d71226e8fc8a6284d210a5d9318ac6d0
- Device class
- Class B
- Brand name
- Chimera
- License holder
- CHIMERA BIOTECH PRIVATE LIMITED
- Approving authority
- South Delhi Division
- Product information
- The Anti-Streptolysin O test is intended to be used for the qualitative detection of antibodies against the Streptolysin O enzyme of group A Streptococci bacteria in human serum
Anti-Streptolysin O test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000113_89e8d53a99969c9ffb913c75f6ee6b05_d71226e8fc8a6284d210a5d9318ac6d0. This device is marketed under the brand name Chimera. The license holder is CHIMERA BIOTECH PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is South Delhi Division.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.